Intel Corporation (NASDAQ:INTC | INTC Price Prediction) stock just earned a strong endorsement from Stifel analyst Ruben Roy, who raised the firm’s price target from $42 to $65 while keeping a Hold rating on the shares. The move signals growing conviction that Intel’s recovery is real, even if Stifel isn’t ready to call it a full buy just yet.
The tension here is worth noting. A target hike of this magnitude reflects meaningful recalibration, but the unchanged Hold rating tells you Stifel sees upside without full confidence in the execution. That’s a useful signal for investors trying to gauge where Intel stands in its turnaround.
| Ticker | Company | Firm | Action | Old Rating | New Rating | Old Target | New Target |
|---|---|---|---|---|---|---|---|
| INTC | Intel Corporation | Stifel | Price Target Change | Hold | Hold | $42 | $65 |
The Analyst’s Case
Roy noted that processor coverage sits at “distinctly different points on the AI infrastructure adoption curve,” but shares a common macro backdrop: compute demand, both accelerated and general purpose, is running materially ahead of prior forecasts. That demand surge is the engine behind the revised target.
The agentic AI wave is a key part of this story. Morgan Stanley projects that agentic AI could add $32.5 to $60 billion to the data-center CPU market by 2030, a tailwind that benefits Intel’s core business directly. Roy’s revised target appears to reflect that longer-horizon opportunity landing sooner than expected.
Company Snapshot
Intel is a global semiconductor leader spanning CPUs, data center chips, and foundry services. CEO Lip-Bu Tan is leading a turnaround anchored by the Intel 18A process node, the most advanced semiconductor manufacturing technology developed and built in the United States, now ramped to high-volume manufacturing in Arizona and Oregon.
NVIDIA (NASDAQ:NVDA) invested $5 billion in Intel common stock, and SoftBank invested $2 billion, adding institutional credibility to the recovery thesis. Intel also received a $5.7 billion CHIPS Act disbursement in Q3 2025, with $8.9 billion in total U.S. government funding committed.
Why the Move Matters Now
Intel stock has already moved sharply this year. Shares are up 79% year-to-date, and the stock touched a 52-week high of $70.33. Stifel’s new $65 target, issued while Intel trades near that level, suggests the firm sees the current price as fair rather than stretched.
Earnings are also a near-term catalyst. Intel reports Q1 2026 results after the market close on April 23. The company guided Q1 revenue of $11.7 billion to $12.7 billion and guided for non-GAAP EPS of $0.00, with supply expected at its lowest point before improving in Q2. The prediction markets currently show an 85% probability that Intel beats quarterly earnings.
What It Means for Your Portfolio
For long-term investors, the Stifel price target raise warrants a closer look, even as the Hold rating keeps expectations grounded. The Intel Foundry’s operating loss of $2.51 billion in Q4 and ongoing supply constraints are real risks that haven’t disappeared. You can read more about the foundry’s path to profitability here.
If you believe Intel’s 18A ramp gains traction and AI-driven CPU demand accelerates, the risk-reward case strengthens considerably. However, if foundry execution stumbles or a major external customer doesn’t materialize, the Hold rating may prove prescient. Watch the Q1 earnings call closely for supply commentary and any foundry customer announcements.
Top Gaining Stocks
Top Losing Stocks